Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:56 AM
Ignite Modification Date: 2025-12-26 @ 1:36 AM
NCT ID: NCT04599933
Description: None
Frequency Threshold: 5
Time Frame: 15 days
Study: NCT04599933
Study Brief: An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Vehicle One drop bilaterally twice daily for approximately 2 weeks. Vehicle: One drop bilaterally twice daily for approximately 2 weeks. 0 None 1 154 3 154 View
CSF-1 One drop bilaterally twice daily for approximately 2 weeks. CSF-1: One drop bilaterally twice daily for approximately 2 weeks. 0 None 0 155 17 155 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Enteritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA 23.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
instillation site pain SYSTEMATIC_ASSESSMENT General disorders MedDRA 23.1 View
headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 23.1 View